
INSIDE (Innovative Solution for Dosimetry in Hadrontherapy), is the first bimodal system in the world capable of monitoring the beams in real time carbon ions and protons used in oncology hadrontherapy to target tumors resistant to X-ray and non-X-ray radiotherapy operable. |
It consists of a PET scanner and a charged particle tracker. |

The CNAO Foundation (Center National Institute of Oncological Hadrontherapy) of Pavia, together with INFN, the Departments of physics at the University of Pisa and at the Sapienza University of Rome, have started to test it on patients, with the aim of verifying the effects of hadrontherapy on tumor tissues even more effectively and making it even more effective precise treatment. |
For this purpose, a clinical study has been started which will involve 40 CNAO patients undergoing hadrontherapy for the treatment of meningiomas and head and neck tumors (adenoidecystic carcinoma, chordoma of the base of the skull, carcinoma of the nasopharynx). |

The INSIDE device in the CNAO treatment room

A Treatment Plan for one of the patients participating in the clinical trial